Intra-Cellular Therapies (NASDAQ:ITCI) Trading Up 6.7%
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Free Report)’s stock price traded up 6.7% during trading on Tuesday . The stock traded as high as $49.48 and last traded at $49.46. 782,313 shares traded hands during trading, an increase of 4% from the average session volume of 752,862 shares. The stock had previously closed at $46.37. […]
More Stories
Sweeney & Michel LLC Has $321,000 Position in Vanguard Short-Term Corporate Bond ETF (NASDAQ:VCSH)
Sweeney & Michel LLC trimmed its position in Vanguard Short-Term Corporate Bond ETF (NASDAQ:VCSH – Free Report) by 3.6% in...
Independent Bank Group (NASDAQ:IBTX) Announces Earnings Results
Independent Bank Group (NASDAQ:IBTX – Get Free Report) issued its quarterly earnings results on Monday. The bank reported $0.50 EPS...
Alexandria Real Estate Equities (NYSE:ARE) Posts Quarterly Earnings Results, Misses Estimates By $1.42 EPS
Alexandria Real Estate Equities (NYSE:ARE – Get Free Report) released its quarterly earnings results on Monday. The real estate investment...
Vanguard High Dividend Yield ETF (NYSEARCA:VYM) is DeDora Capital Inc.’s 2nd Largest Position
DeDora Capital Inc. grew its holdings in Vanguard High Dividend Yield ETF (NYSEARCA:VYM – Free Report) by 0.9% in the...
Raleigh Capital Management Inc. Sells 4,955 Shares of Chevron Co. (NYSE:CVX)
Raleigh Capital Management Inc. trimmed its stake in Chevron Co. (NYSE:CVX – Free Report) by 33.4% during the 3rd quarter,...
Graybill Wealth Management LTD. Lowers Position in United Rentals, Inc. (NYSE:URI)
Graybill Wealth Management LTD. reduced its stake in United Rentals, Inc. (NYSE:URI – Free Report) by 2.8% during the 3rd...